Literature DB >> 18602936

Coactivator PGC-1alpha regulates the fasting inducible xenobiotic-metabolizing enzyme CYP2A5 in mouse primary hepatocytes.

Satu Arpiainen1, Sanna-Mari Järvenpää, Aki Manninen, Pirkko Viitala, Matti A Lang, Olavi Pelkonen, Jukka Hakkola.   

Abstract

The nutritional state of organisms and energy balance related diseases such as diabetes regulate the metabolism of xenobiotics such as drugs, toxins and carcinogens. However, the mechanisms behind this regulation are mostly unknown. The xenobiotic-metabolizing cytochrome P450 (CYP) 2A5 enzyme has been shown to be induced by fasting and by glucagon and cyclic AMP (cAMP), which mediate numerous fasting responses. Peroxisome proliferator-activated receptor gamma coactivator (PGC)-1alpha triggers many of the important hepatic fasting effects in response to elevated cAMP levels. In the present study, we were able to show that cAMP causes a coordinated induction of PGC-1alpha and CYP2A5 mRNAs in murine primary hepatocytes. Furthermore, the elevation of the PGC-1alpha expression level by adenovirus mediated gene transfer increased CYP2A5 transcription. Co-transfection of Cyp2a5 5' promoter constructs with the PGC-1alpha expression vector demonstrated that PGC-1alpha is able to activate Cyp2a5 transcription through the hepatocyte nuclear factor (HNF)-4alpha response element in the proximal promoter of the Cyp2a5 gene. Chromatin immunoprecipitation assays showed that PGC-1alpha binds, together with HNF-4alpha, to the same region at the Cyp2a5 proximal promoter. In conclusion, PGC-1alpha mediates the expression of Cyp2a5 induced by cAMP in mouse hepatocytes through coactivation of transcription factor HNF-4alpha. This strongly suggests that PGC-1alpha is the major factor mediating the fasting response of CYP2A5.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18602936     DOI: 10.1016/j.taap.2008.06.001

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  12 in total

Review 1.  Alcoholic Liver Disease: from CYP2E1 to CYP2A5.

Authors:  Tung Ming Leung; Yongke Lu
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

2.  Fasting-Induced Transcription Factors Repress Vitamin D Bioactivation, a Mechanism for Vitamin D Deficiency in Diabetes.

Authors:  Sanna-Mari Aatsinki; Mahmoud-Sobhy Elkhwanky; Outi Kummu; Mikko Karpale; Marcin Buler; Pirkko Viitala; Valtteri Rinne; Maija Mutikainen; Pasi Tavi; Andras Franko; Rudolf J Wiesner; Kari T Chambers; Brian N Finck; Jukka Hakkola
Journal:  Diabetes       Date:  2019-03-04       Impact factor: 9.461

3.  Research Resource: A Reference Transcriptome for Constitutive Androstane Receptor and Pregnane X Receptor Xenobiotic Signaling.

Authors:  Scott A Ochsner; Anna Tsimelzon; Jianrong Dong; Cristian Coarfa; Neil J McKenna
Journal:  Mol Endocrinol       Date:  2016-07-13

4.  Energy-sensing factors coactivator peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α) and AMP-activated protein kinase control expression of inflammatory mediators in liver: induction of interleukin 1 receptor antagonist.

Authors:  Marcin Buler; Sanna-Mari Aatsinki; Réka Skoumal; Zsolt Komka; Miklós Tóth; Risto Kerkelä; Anastasia Georgiadi; Sander Kersten; Jukka Hakkola
Journal:  J Biol Chem       Date:  2011-11-23       Impact factor: 5.157

5.  Ethanol induction of CYP2A5: role of CYP2E1-ROS-Nrf2 pathway.

Authors:  Yongke Lu; Xu Hannah Zhang; Arthur I Cederbaum
Journal:  Toxicol Sci       Date:  2012-05-02       Impact factor: 4.849

6.  Alcohol Upregulation of CYP2A5: Role of Reactive Oxygen Species.

Authors:  Yongke Lu; Arthur I Cederbaum
Journal:  React Oxyg Species (Apex)       Date:  2016-03

7.  Metformin induces PGC-1α expression and selectively affects hepatic PGC-1α functions.

Authors:  Sanna-Mari Aatsinki; Marcin Buler; Henriikka Salomäki; Markku Koulu; Petr Pavek; Jukka Hakkola
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

8.  Three-dimensional culture and cAMP signaling promote the maturation of human pluripotent stem cell-derived hepatocytes.

Authors:  Shinichiro Ogawa; James Surapisitchat; Carl Virtanen; Mina Ogawa; Maryam Niapour; Kim S Sugamori; Shuang Wang; Laura Tamblyn; Chantal Guillemette; Ewa Hoffmann; Bin Zhao; Stephen Strom; Rebecca R Laposa; Rachel F Tyndale; Denis M Grant; Gordon Keller
Journal:  Development       Date:  2013-08       Impact factor: 6.868

Review 9.  Cytochrome P450s and Alcoholic Liver Disease.

Authors:  Yongke Lu; Arthur I Cederbaum
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

10.  Metformin reduces hepatic expression of SIRT3, the mitochondrial deacetylase controlling energy metabolism.

Authors:  Marcin Buler; Sanna-Mari Aatsinki; Valerio Izzi; Jukka Hakkola
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.